These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

859 related articles for article (PubMed ID: 6561202)

  • 21. Initiation of contact activation by sulfatides.
    Tans G; Griffin JH
    Adv Exp Med Biol; 1983; 156():63-72. PubMed ID: 6602464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms for Hageman factor activation and role of HMW kininogen as a coagulation cofactor.
    Kaplan AP; Silverberg M; Dunn JT; Miller G
    Ann N Y Acad Sci; 1981; 370():253-60. PubMed ID: 6455951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface.
    DeLa Cadena RA; Colman RW
    Protein Sci; 1992 Jan; 1(1):151-60. PubMed ID: 1304876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Properties of sulfatides in factor-XII-dependent contact activation.
    Tans G; Griffin JH
    Blood; 1982 Jan; 59(1):69-75. PubMed ID: 6914902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The contact activation mechanism in human plasma: activation induced by dextran sulfate.
    van der Graaf F; Keus FJ; Vlooswijk RA; Bouma BN
    Blood; 1982 Jun; 59(6):1225-33. PubMed ID: 6177360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormalities in the contact activation through factor XII in Fujiwara trait: a deficiency in both high and low molecular weight kininogens with low level of prekallikrein.
    Oh-ishi S; Ueno A; Uchida Y; Katori M; Hayashi H; Koya H; Kitajima K; Kimura I
    Tohoku J Exp Med; 1981 Jan; 133(1):67-80. PubMed ID: 6785899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and quantitation of cleaved and uncleaved high molecular weight kininogen in plasma by ligand blotting with radiolabeled plasma prekallikrein or factor XI.
    Lämmle B; Zuraw BL; Heeb MJ; Schwarz HP; Berrettini M; Curd JG; Griffin JH
    Thromb Haemost; 1988 Apr; 59(2):151-61. PubMed ID: 3388291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).
    Griffin JH
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1998-2002. PubMed ID: 273926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissemination of contact activation in plasma by plasma kallikrein.
    Cochrane CG; Revak SD
    J Exp Med; 1980 Sep; 152(3):608-19. PubMed ID: 6902742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma.
    Reddigari S; Kaplan AP
    Blood; 1988 May; 71(5):1334-40. PubMed ID: 2451949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-coagulant protein interactions in contact activation.
    Walsh PN; Griffin JH
    Ann N Y Acad Sci; 1981; 370():241-52. PubMed ID: 7023319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural and functional characterization of factor XII.
    Tans G; Rosing J
    Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of factor XII, high-molecular-weight (HMW) kininogen and prekallikrein with sulfatide: analysis by fluorescence polarization.
    Shimada T; Kato H; Maeda H; Iwanaga S
    J Biochem; 1985 Jun; 97(6):1637-44. PubMed ID: 3928613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein.
    Wiggins RC
    J Biol Chem; 1983 Jul; 258(14):8963-70. PubMed ID: 6553057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of the participation of the contact system in the Vroman effect. Review and summary.
    Scott CF
    J Biomater Sci Polym Ed; 1991; 2(3):173-81. PubMed ID: 1854683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amidolytic assay of human factor XI in plasma: comparison with a coagulant assay and a new rapid radioimmunoassay.
    Scott CF; Sinha D; Seaman FS; Walsh PN; Colman RW
    Blood; 1984 Jan; 63(1):42-50. PubMed ID: 6606454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletion mutagenesis of high molecular weight kininogen light chain. Identification of two anionic surface binding subdomains.
    Kunapuli SP; DeLa Cadena RA; Colman RW
    J Biol Chem; 1993 Feb; 268(4):2486-92. PubMed ID: 8428925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of factor XII and prekallikrein with cholesterol sulfate.
    Shimada T; Kato H; Iwanaga S; Iwamori M; Nagai Y
    Thromb Res; 1985 Apr; 38(1):21-31. PubMed ID: 3847226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of factor XI in plasma is dependent on factor XII.
    Brunnée T; La Porta C; Reddigari SR; Salerno VM; Kaplan AP; Silverberg M
    Blood; 1993 Feb; 81(3):580-6. PubMed ID: 8427954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural changes of plasma high molecular weight kininogen after in vitro activation and in sepsis.
    Schmaier AH; Farber A; Schein R; Sprung C
    J Lab Clin Med; 1988 Aug; 112(2):182-92. PubMed ID: 2456360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.